A 6-year-old child presents with bilateral follicular conjunctivitis, mild mucoid discharge, and preauricular lymphadenopathy for 10 days. The child attends school and has no systemic symptoms. Gram stain and culture are negative for bacteria. Giemsa stain shows intracytoplasmic inclusion bodies in epithelial cells. What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis **Key Point:** Intracytoplasmic inclusion bodies on Giemsa stain in a child with subacute follicular conjunctivitis and negative bacterial cultures is diagnostic of *Chlamydia trachomatis* (chlamydial conjunctivitis). **High-Yield:** Chlamydial conjunctivitis in children is typically acquired from infected mothers during birth (neonatal) or from contaminated fomites/hand contact (paediatric). It requires systemic therapy to prevent recurrence and eliminate nasopharyngeal carriage. ## Management Algorithm ```mermaid flowchart TD A[Follicular conjunctivitis + Giemsa inclusions]:::outcome --> B{Age and presentation?}:::decision B -->|Neonatal or paediatric| C[Systemic chlamydia likely]:::outcome C --> D[Oral azithromycin 10 mg/kg/day x 3 days]:::action D --> E[Topical tetracycline or erythromycin ointment]:::action E --> F[Screen for other STIs in mother/contacts]:::action F --> G[Counsel on hygiene, prevent spread]:::action G --> H[Follow-up at 2-4 weeks]:::outcome ``` ## Why Systemic Therapy is Mandatory **Clinical Pearl:** Topical antibiotics alone do NOT eradicate nasopharyngeal chlamydia, leading to: - Recurrent conjunctivitis - Chronic follicular response - Risk of trachoma in endemic areas - Persistent carriage and transmission ### Antibiotic Selection | Drug | Dose (Child) | Duration | Notes | |------|-------------|----------|-------| | **Azithromycin** | 10 mg/kg/day | 3 days | **First-line**; good tissue penetration; single daily dose | | Doxycycline | 2–4 mg/kg/day | 7 days | Contraindicated <8 years (teeth staining) | | Erythromycin | 12.5 mg/kg QID | 7–14 days | Alternative; GI side effects common | | Tetracycline ointment | Topical | 4 times daily | **Adjunctive only**; insufficient systemic levels | **Warning:** Topical erythromycin or tetracycline alone is inadequate for chlamydial conjunctivitis—systemic therapy is essential. ## Associated Findings to Screen - **Maternal history:** Cervicitis, urethritis, or untreated chlamydia during pregnancy - **Sibling involvement:** Chlamydia spreads via contaminated secretions - **Systemic complications:** Pneumonitis (5–15% of infected neonates at 2–12 weeks) - **Other STIs:** Test mother and sexual contacts for gonorrhea, syphilis, HIV [cite:Harrison 21e Ch 137; Kanski & Bowling Clinical Ophthalmology 9e Ch 4]